Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression
Open Access
- 23 February 2022
- journal article
- review article
- Published by Elsevier BV in The Lancet
- Vol. 399 (10328), 924-944
- https://doi.org/10.1016/s0140-6736(22)00152-0
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Waning antibody responses in COVID-19: what can we learn from the analysis of other coronaviruses?Infection, 2022
- Effectiveness of an Inactivated SARS-CoV-2 Vaccine in ChileThe New England Journal of Medicine, 2021
- Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 VaccinesThe New England Journal of Medicine, 2021
- Real-world effectiveness of BNT162b2 mRNA vaccine: a meta-analysis of large observational studiesInflammopharmacology, 2021
- Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infectionNature Medicine, 2021
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 VaccineThe New England Journal of Medicine, 2021
- RoB 2: a revised tool for assessing risk of bias in randomised trialsBMJ, 2019
- ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventionsBMJ, 2016
- Effect of Immunoglobulin Therapy on the Rate of Infections in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation and or treated with immunomodulatory agentsMediterranean Journal of Hematology and Infectious Diseases, 2010
- Statistical methods in cancer research. Volume II--The design and analysis of cohort studies.1987